Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010–2015

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 11, 2016, Pages 1513-1525

  Bousquet, J ^a,b,c   Anto, J M ^d,e,f,g   Akdis, M ^h   Auffray, C ⁱ   Keil, T ^j,k   Momas, I ^l,m   Postma, D S ⁿ   Valenta, R ^o   Wickman, M ^p   Cambon Thomsen, A ^q   Haahtela, T ^r   Lambrecht, B N ^s   Lodrup Carlsen, K C ^t   Koppelman, G H ^u   Sunyer, J ^d,e,f,g   Zuberbier, T ^j   Annesi Maesano, I ^v   Arno, A ^w   Bindslev Jensen, C ^x   De Carlo, G ^y   Forastiere, F ^z   Heinrich, J ^aa   Kowalski, M L ^ab   Maier, D ^ac   Melen E ^n,ad   Palkonen, S ^y   Smit, H A ^ae   Standl, M ^aa   Wright, J ^af   Asarnoj, A ^ag,ah   Benet, M ^d   Ballardini, N ^p,ai   Garcia Aymerich, J ^d,e,f,g   Gehring, U ^aj   Guerra, S ^d   Hohman, C ^j   Kull, I ^p,ag   Lupinek, C ^o   Pinart, M ^d   Skrindo, I ^t   Westman, M ^ag,ah   Smagghe, D ^v   Akdis, C ^h   Albang, R ^ac   Anastasova, V ^q   Anderson, N ^ag   Bachert, C ^ak   Ballereau, S ⁱ   Ballester, F ^al   Basagana, X ^d   Bedbrook, A ^b   Bergstrom, A ^ag   von Berg, A ^am   Brunekreef, B ^ae   Burte, E ^c   Carlsen, K H ^t   Chatzi, L ^an   Coquet, J M ^s   Curin, M ^o   Demoly, P ^a   Eller, E ^x   Fantini, M P ^ao   Gerhard, B ^ac   Hammad, H ^s   von Hertzen, L ^r   Hovland, V ^t   Jacquemin, B ^d   Just, J ^ap   Keller, T ^j   Kerkhof, M ⁿ   Kiss, R ^o   Kogevinas, M ^d,e,f,g   Koletzko, S ^aq   Lau, S ^j   Lehmann, I ^ar   Lemonnier, N ⁱ   McEachan, R ^af   Makela M ^r   Mestres, J ^b,c   Minina, E ^ac   Mowinckel, P ^t   Nadif, R ^c   Nawijn, M ^u   Oddie, S ^af   Pellet, J ⁱ   Pin, I ^as   Porta, D ^z   Ranciere F ^l   Rial Sebbag, A ^q   Saeys, Y ^s   Schuijs, M J ^s   Siroux, V ^v   Tischer, C G ^aa   Torrent, M ^d,at   Varraso, R ^c   De Vocht, J ^y   Wenger, K ^ac   Wieser, S ^o   Xu, C ⁿ   more..

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b MACVIA LR   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g UNIVERSITAT POMPEU FABRA   (Spain)

^h UNIVERSITY OF ZURICH   (Switzerland)

ⁱ UNIVERSITÉ DE LYON   (France)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k UNIVERSITY OF WÜRZBURG   (Germany)

^l PARIS DESCARTES SORBONNE PARIS CITÉ UNIVERSITY   (France)

^m Paris Municipal Department of Social Action Childhood and Health   (France)

ⁿ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^o MEDICAL UNIVERSITY OF VIENNA   (Austria)

^p STOCKHOLM SÖDER HOSPITAL   (Sweden)

^q UNIVERSITÉ DE TOULOUSE   (France)

^r HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^s GHENT UNIVERSITY   (Belgium)

^t OSLO UNIVERSITY HOSPITAL   (Norway)

^u UNIVERSITY OF GRONINGEN   (Netherlands)

^v INSERM   (France)

^w Onmedic Networks   (Spain)

^x ODENSE UNIVERSITY HOSPITAL   (Denmark)

^y EFA European Federation of Allergy and Airways Diseases Patients' Associations   (Belgium)

^z DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^aa INSTITUTE OF EPIDEMIOLOGY   (Germany)

^ab MEDICAL UNIVERSITY OF LODZ   (Poland)

^ac Biomax Informatics AG   (Germany)

^ad STOCKHOLM COUNTY COUNCIL   (Sweden)

^ae UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^af BRADFORD INSTITUTE FOR HEALTH RESEARCH   (United Kingdom)

^ag KAROLINSKA INSTITUTE   (Sweden)

^ah KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ai KING'S COLLEGE LONDON   (United Kingdom)

^aj UTRECHT UNIVERSITY   (Netherlands)

^ak GHENT UNIVERSITY HOSPITAL   (Belgium)

^al UNIVERSITY OF VALENCIA   (Spain)

^am Marien Hospital   (Germany)

^an UNIVERSITY OF CRETE   (Greece)

^ao UNIVERSITY OF BOLOGNA   (Italy)

^ap SORBONNE UNIVERSITÉ   (France)

^aq UNIVERSITY OF MUNICH   (Germany)

^ar HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^as GRENOBLE UNIVERSITY HOSPITAL   (France)

^at IB SALUT   (Spain)

more..

Author keywords

asthma; IgE; multimorbidity; polysensitization; rhinitis

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E;

ALLERGIC DISEASE; ASTHMA; BIOINFORMATICS; DISEASE CLASSIFICATION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; HUMAN; IMMUNOTHERAPY; MACHINE LEARNING; MICROARRAY ANALYSIS; MORBIDITY; NONHUMAN; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SENSITIZATION; SYSTEMS BIOLOGY; DISEASE MANAGEMENT; EUROPEAN UNION; HEALTH CARE POLICY; HYPERSENSITIVITY; IMMUNIZATION; IMMUNOLOGY; INVENTION; PROCEDURES; PROGNOSIS; WORLD HEALTH ORGANIZATION;

DISEASE MANAGEMENT; EUROPEAN UNION; HEALTH POLICY; HUMANS; HYPERSENSITIVITY; IMMUNIZATION; IMMUNOGLOBULIN E; INVENTIONS; PRECISION MEDICINE; PROGNOSIS; SYSTEMS BIOLOGY; WORLD HEALTH ORGANIZATION;

EID: 84990872120     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12880     Document Type: Review

References (95)

1. Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011;66:596–604.
2. Bousquet J, Anto JM, Wickman M, Keil T, Valenta R, Haahtela T et al. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis Allergy 2015;70:1062–1078.
3. Martinez FD. Genes, environments, development and asthma: a reappraisal. Eur Respir J 2007;29:179–184.
4. Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J et al. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 2011;3:43.
5. Anto JM, Pinart M, Akdis M, Auffray C, Bachert C, Basagana X et al. Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol 2012;129:943–954.
6. Bousquet J, Gern JE, Martinez FD, Anto JM, Johnson CC, Holt PG et al. Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop. J Allergy Clin Immunol 2014;133:1535–1546.
7. Molter A, Simpson A, Berdel D, Brunekreef B, Custovic A, Cyrys J et al. A multicentre study of air pollution exposure and childhood asthma prevalence: the ESCAPE project. Eur Respir J 2015;45:610–624.
8. Fuertes E, MacIntyre E, Agius R, Beelen R, Brunekreef B, Bucci S et al. Associations between particulate matter elements and early-life pneumonia in seven birth cohorts: results from the ESCAPE and TRANSPHORM projects. Int J Hyg Environ Health 2014;217:819–829.
9. Pedersen M, Giorgis-Allemand L, Bernard C, Aguilera I, Andersen AM, Ballester F et al. Ambient air pollution and low birthweight: a European cohort study (ESCAPE). Lancet Respir Med 2013;1:695–704.
10. Eeftens M, Beelen R, de Hoogh K, Bellander T, Cesaroni G, Cirach M et al. Development of land use regression models for PM(2.5), PM(2.5) absorbance, PM(10) and PM(coarse) in 20 European study areas; results of the ESCAPE project. Environ Sci Technol 2012;46:11195–11205.
11. Hohmann C, Pinart M, Tischer C, Gehring U, Heinrich J, Kull I et al. The development of the MeDALL core questionnaires for a harmonized follow-up assessment of eleven European birth cohorts on asthma and allergies. Int Arch Allergy Immunol 2014;163:215–224.
12. Bousquet J, Anto J, Sunyer J, Nieuwenhuijsen M, Vrijheid M, Keil T et al. Pooling birth cohorts in allergy and asthma: European Union-funded initiatives–a MeDALL, CHICOS, ENRIECO, and GA(2)LEN joint paper. Int Arch Allergy Immunol 2013;161:1–10.
13. Sucharew H, Ryan PH, Bernstein D, Succop P, Khurana Hershey GK, Lockey J et al. Exposure to traffic exhaust and night cough during early childhood: the CCAAPS birth cohort. Pediatr Allergy Immunol 2010;21(Pt 1):253–259.
14. Garcia Algar O, Pichini S, Basagana X, Puig C, Vall O, Torrent M et al. Concentrations and determinants of NO2 in homes of Ashford, UK and Barcelona and Menorca, Spain. Indoor Air 2004;14:298–304.
15. Wickman M, Kull I, Pershagen G, Nordvall SL. The BAMSE project: presentation of a prospective longitudinal birth cohort study. Pediatr Allergy Immunol 2002;13(Suppl 15):11–13.
16. Wright J, Small N, Raynor P, Tuffnell D, Bhopal R, Cameron N et al. Cohort profile: the Born in Bradford multi-ethnic family cohort study. Int J Epidemiol 2013;42:978–991.
17. Raynor P. Born in Bradford, a cohort study of babies born in Bradford, and their parents: protocol for the recruitment phase. BMC Public Health 2008;8:327.
18. Host A, Halken S, Jacobsen HP, Christensen AE, Herskind AM, Plesner K. Clinical course of cow's milk protein allergy/intolerance and atopic diseases in childhood. Pediatr Allergy Immunol 2002;13(Suppl 15):23–28.
19. Lodrup Carlsen KC. The environment and childhood asthma (ECA) study in Oslo: ECA-1 and ECA-2. Pediatr Allergy Immunol 2002;13(Suppl 15):29–31.
20. Slama R, Thiebaugeorges O, Goua V, Aussel L, Sacco P, Bohet A et al. Maternal personal exposure to airborne benzene and intrauterine growth. Environ Health Perspect 2009;117:1313–1321.
21. Laubereau B, Brockow I, Zirngibl A, Koletzko S, Gruebl A, von Berg A et al. Effect of breast-feeding on the development of atopic dermatitis during the first 3 years of life–results from the GINI-birth cohort study. J Pediatr 2004;144:602–607.
22. Berg AV, Kramer U, Link E, Bollrath C, Heinrich J, Brockow I et al. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course–the GINIplus study up to the age of 6 years. Clin Exp Allergy 2010;40:627–636.
23. Aguilera I, Guxens M, Garcia-Esteban R, Corbella T, Nieuwenhuijsen MJ, Foradada CM et al. Association between GIS-based exposure to urban air pollution during pregnancy and birth weight in the INMA Sabadell cohort. Environ Health Perspect 2009;117:1322–1327.
24. Heinrich J, Bolte G, Holscher B, Douwes J, Lehmann I, Fahlbusch B et al. Allergens and endotoxin on mothers’ mattresses and total immunoglobulin E in cord blood of neonates. Eur Respir J 2002;20:617–623.
25. Nickel R, Niggemann B, Gruber C, Kulig M, Wahn U, Lau S. How should a birth cohort study be organised? Experience from the German MAS cohort study. Paediatr Respir Rev 2002;3:169–176.
26. Illi S, von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004;113:925–931.
27. Nickel R, Illi S, Lau S, Sommerfeld C, Bergmann R, Kamin W et al. Variability of total serum immunoglobulin E levels from birth to the age of 10 years. A prospective evaluation in a large birth cohort (German multicenter allergy study). Clin Exp Allergy 2005;35:619–623.
28. Illi S, von Mutius E, Lau S, Niggemann B, Gruber C, Wahn U. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006;368:763–770.
29. Clarisse B, Demattei C, Nikasinovic L, Just J, Daures JP, Momas I. Bronchial obstructive phenotypes in the first year of life among Paris birth cohort infants. Pediatr Allergy Immunol 2009;20:126–133.
30. Wijga A, Smit HA, Brunekreef B, Gerritsen J, Kerkhof M, Koopman LP et al. Are children at high familial risk of developing allergy born into a low risk environment? The PIAMA birth cohort study. Prevention and incidence of asthma and mite allergy. Clin Exp Allergy 2001;31:576–581.
31. Chatzi L, Plana E, Daraki V, Karakosta P, Alegkakis D, Tsatsanis C et al. Metabolic syndrome in early pregnancy and risk of preterm birth. Am J Epidemiol 2009;170:829–836.
32. Porta D, Forastiere F, Di Lallo D, Perucci CA. Enrolment and follow-up of a birth cohort in Rome. Epidemiol Prev 2007;31:303–308.
33. Maier D, Kalus W, Wolff M, Kalko SG, Roca J, Marin de Mas I et al. Knowledge management for systems biology a general and visually driven framework applied to translational medicine. BMC Syst Biol 2011;5:38.
34. Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, Broecker BM et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods 2014;66:106–119.
35. Skrindo I, Lupinek C, Valenta R, Hovland V, Pahr S, Baar A et al. The use of the MeDALL-chip to assess IgE sensitization: a new diagnostic tool for allergic disease? Pediatr Allergy Immunol 2015;26:239–246.
36. Westman M, Lupinek C, Bousquet J, Andersson N, Pahr S, Baar A et al. Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. J Allergy Clin Immunol 2015;135:1199–1206.
37. Asarnoj A, Hamsten C, Waden K, Lupinek C, Andersson N, Kull I et al. Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: a BAMSE/MeDALL study. J Allergy Clin Immunol 2016;137:813–821.
38. Pinart M, Albang R, Maier D, Duran-Tauleria E, Mena G, Gimeno-Santos E et al. Systematic review on the definition of allergic diseases in children: the MeDALL study. Int Arch Allergy Immunol 2015;168:110–121.
39. Belgrave DC, Buchan I, Bishop C, Lowe L, Simpson A, Custovic A. Trajectories of lung function during childhood. Am J Respir Crit Care Med 2014;189:1101–1109.
40. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147–S334.
41. Pinart M, Benet M, Annesi-Maesano I, von Berg A, Berdel D, Carlsen KC et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med 2014;2:131–140.
42. Garcia-Aymerich J, Benet M, Saeys Y, Pinart M, Basagana X, Smit HA et al. Phenotyping asthma, rhinitis and eczema in MeDALL population-based birth cohorts: an allergic comorbidity cluster. Allergy 2015;70:973–984.
43. Bousquet J, Becker WM, Hejjaoui A, Chanal I, Lebel B, Dhivert H et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991;88:43–53.
44. Bousquet J, Hejjaoui A, Becker WM, Cour P, Chanal I, Lebel B et al. Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species. I. Clinical and immunologic characteristics. J Allergy Clin Immunol 1991;87:737–746.
45. Pene J, Rivier A, Lagier B, Becker WM, Michel FB, Bousquet J. Differences in IL-4 release by PBMC are related with heterogeneity of atopy. Immunology 1994;81:58–64.
46. Ballardini N, Bergstrom A, Wahlgren CF, van Hage M, Hallner E, Kull I et al. IgE antibodies in relation to prevalence and multimorbidity of eczema, asthma, and rhinitis from birth to adolescence. Allergy 2016;71:342–349.
47. Just J, Deslandes-Boutmy E, Amat F, Desseaux K, Nemni A, Bourrat E et al. Natural history of allergic sensitization in infants with early-onset atopic dermatitis: results from ORCA study. Pediatr Allergy Immunol 2014;25:668–673.
48. Burte E, Bousquet J, Varraso R, Gormand F, Just J, Matran R et al. Characterization of rhinitis according to the asthma status in adults using an unsupervised approach in the EGEA study. PLoS One 2015;10:e0136191.
49. Gehring UW, Hoek A, Bellander G, Berdel T, Brüske D, Fuertes I et al. Exposure to air pollution and development of asthma and rhinoconjunctivitis throughout childhood and adolescence: a population-based birth cohort study. Lancet Respir Med 2015;3:933–942.
50. Guerra S, Halonen M, Vasquez MM, Spangenberg A, Stern DA, Morgan WJ et al. Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study. Lancet Respir Med 2015;3:613–620.
51. Coquet JM, Schuijs MJ, Smyth MJ, Deswarte K, Beyaert R, Braun H et al. Interleukin-21-producing CD4(+) T cells promote type 2 immunity to house dust mites. Immunity 2015;43:318–330.
52. Schuijs MJ, Willart MA, Vergote K, Gras D, Deswarte K, Ege MJ et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 2015;349:1106–1110.
53. Palomares O, Ruckert B, Jartti T, Kucuksezer UC, Puhakka T, Gomez E et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol 2012;129:510–520.
54. Palomares O, Martin-Fontecha M, Lauener R, Traidl-Hoffmann C, Cavkaytar O, Akdis M et al. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-beta. Genes Immun 2014;15:511–520.
55. Kucuksezer UC, Palomares O, Ruckert B, Jartti T, Puhakka T, Nandy A et al. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J Allergy Clin Immunol 2013;131:875–885.
56. Stanic B, van de Veen W, Wirz OF, Ruckert B, Morita H, Sollner S et al. IL-10-overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol 2015;135:771–780.
57. van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Sollner S, Akdis DG et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 2013;131:1204–1212.
58. Wegrzyn AS, Jakiela B, Ruckert B, Jutel M, Akdis M, Sanak M et al. T-cell regulation during viral and nonviral asthma exacerbations. J Allergy Clin Immunol 2015;136:194–197.
59. Wawrzyniak M, Ochsner U, Wirz O, Wawrzyniak P, van de Veen W, Akdis CA et al. A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A. Allergy 2016;71:47–57.
60. Kast JI, Wanke K, Soyka MB, Wawrzyniak P, Akdis D, Kingo K et al. The broad spectrum of interepithelial junctions in skin and lung. J Allergy Clin Immunol 2012;130:544–547.
61. Soyka MB, Holzmann D, Akdis CA. Regulatory cells in allergen-specific immunotherapy. Immunotherapy 2012;4:389–396.
62. Kubo T, Wawrzyniak P, Morita H, Sugita K, Wanke K, Kast JI et al. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier. J Allergy Clin Immunol 2015;136:1413–1416.
63. Smit HA, Pinart M, Anto JM, Keil T, Bousquet J, Carlsen KH et al. Childhood asthma prediction models: a systematic review. Lancet Respir Med 2015;3:973–984.
64. Bousquet PJ, Devillier P, Tadmouri A, Mesbah K, Demoly P, Bousquet J. Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study. Int Arch Allergy Immunol 2015;166:231–240.
65. Canonica GW, Bachert C, Hellings P, Ryan D, Valovirta E, Wickman M et al. Allergen immunotherapy (AIT): a prototype of precision medicine. World Allergy Organ J 2015;8:31.
66. 2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’. Allergy 2009;64:969–977.
67. Kauffmann F, Cambon-Thomsen A. Tracing biological collections: between books and clinical trials. JAMA 2008;299:2316–2318.
68. Anastasova V, Mahalatchimy A, Rial-Sebbag E, Anto Boque JM, Keil T, Sunyer J et al. Communication of results and disclosure of incidental findings in longitudinal paediatric research. Pediatr Allergy Immunol 2013;24:389–394.
69. Bousquet J, Kiley J, Bateman ED, Viegi G, Cruz AA, Khaltaev N et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010;36:995–1001.
70. Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy 2007;62:216–223.
71. Bousquet J, Khaltaev N. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases. A Comprehensive Approach. Global Alliance Against Chronic Respiratory Diseases. Geneva, Switzerland: World Health Organization, 2007: 148 pages. ISBN 978 92 4 156346 8.
72. Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization consultation on severe asthma. J Allergy Clin Immunol 2010;126:926–938.
73. Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 2014;44:304–323.
74. Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes N et al. AIRWAYS ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J 2016;47:1028–1033.
75. Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy 2015;70:1372–1392.
76. Bousquet J, Bourquin C, Augé P, Domy P, Bringer J, Camuzat T et al. MACVIA-LR reference site of the European innovation partnership on active and healthy ageing. Eur GeriatrMed 2014;5:406–415.
77. Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M. The European innovation partnership on active and healthy ageing: the European geriatric medicine introduces the EIP on AHA column. Eur Geriatr Med 2014;5:361–362.
78. Bousquet J, Mercier J, Avignon A, Bourret R, Camuzat T. MACVIA-LR (France) case study. Report EUR 27150 EN. In: Abadie F, editor. Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS3). JRC94487. Luxembourg: Publications Office of the European Union: JRC (Joint Research Centre) Science and Policy Report, 2015: https://ec.europa.eu/jrc.
79. Samolinski B, Fronczak A, Kuna P, Akdis CA, Anto JM, Bialoszewski AZ et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 2012;67:726–731.
80. Samolinski B, Fronczak A, Wlodarczyk A, Bousquet J. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet 2012;379:e45–e46.
81. Bousquet J, Tanasescu CC, Camuzat T, Anto JM, Blasi F, Neou A et al. Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union parliament. Allergy 2013;68:555–561.
82. Bousquet J, Anto JM, Berkouk K, Gergen P, Antunes JP, Auge P et al. Developmental determinants in non-communicable chronic diseases and ageing. Thorax 2015;70:595–597.
83. Samolinski B, Raciborski F, Bousquet J, Kosiniak-Kamysz W, Radziewicz-Winnicki I, Kłak A et al. Development of senioral policy in Poland. Eur Geriatr Med 2015;6:389–395.
84. Haahtela T, von Hertzen L, Makela M, Hannuksela M. Finnish allergy programme 2008–2018–time to act and change the course. Allergy 2008;63:634–645.
85. Lodrup Carlsen KC, Haahtela T, Carlsen KH, Smith A, Bjerke M, Wickman M et al. Integrated allergy and asthma prevention and care: report of the MeDALL/AIRWAYS ICPs meeting at the Ministry of Health and Care Services, Oslo, Norway. Int Arch Allergy Immunol 2015;167:57–64.
86. Just J, Gouvis-Echraghi R, Couderc R, Guillemot-Lambert N, Saint-Pierre P. Novel severe wheezy young children phenotypes: boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze. J Allergy Clin Immunol 2012;130:103–110.
87. Just J, Gouvis-Echraghi R, Rouve S, Wanin S, Moreau D, Annesi-Maesano I. Two novel, severe asthma phenotypes identified during childhood using a clustering approach. Eur Respir J 2012;40:55–60.
88. Price DB, Rigazio A, Campbell JD, Bleecker ER, Corrigan CJ, Thomas M et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med 2015;3:849–858.
89. Angus DC. Fusing randomized trials with big data: the key to self-learning health care systems? JAMA 2015;314:767–768.
90. Herr M, Just J, Nikasinovic L, Foucault C, Le Marec AM, Giordanella JP et al. Risk factors and characteristics of respiratory and allergic phenotypes in early childhood. J Allergy Clin Immunol 2012;130:389–396.
91. Bousquet J, Jorgensen C, Dauzat M, Cesario A, Camuzat T, Bourret R et al. Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Curr Pharm Des 2014;20:5928–5944.
92. Gough H, Grabenhenrich L, Reich A, Eckers N, Nitsche O, Schramm D et al. Allergic multimorbidity of asthma, rhinitis, and eczema over 20 years in the German birth cohort MAS. Pediatr Allergy Immunol 2015;26:431–437.
93. Bousquet J, Anto JM, Bachert C, Bousquet PJ, Colombo P, Crameri R et al. Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GALEN project. Allergy 2006;61:671–680.
94. Amaral AF, Minelli C, Guerra S, Wjst M, Probst-Hensch N, Pin I et al. The locus C11orf30 increases susceptibility to poly-sensitization. Allergy 2015;70:328–333.
95. Ferreira MA, Matheson MC, Tang CS, Granell R, Ang W, Hui J et al. Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype. J Allergy Clin Immunol 2014;133:1564–1571.